-
Mashup Score: 2
Background: Primary infection with or reactivation of Epstein–Barr virus (EBV) can occur after liver transplant (LT) and can lead to posttransplant lymphoproliferative disease (PTLD). In pediatric LT, an EBV-DNA viral load (EBV VL) monitoring strategy, including the reduction of immunosuppression, has led to a lower incidence of PTLD. For adult LT recipients with less primary infection and more…
Source: Annals of Internal MedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
Post-transplant lymphoproliferative disorder (PTLD) is a rare but life-threatening complication after transplantation. In this retrospective, monocentric study we aimed to collect real life data regarding PTLD and determine the role of Epstein Barr Virus (EBV) status and year of diagnosis on prognosis. We identified 196 biopsy-proven PTLD after solid organ transplantation (SOT) diagnosed at the…
Source: FrontiersCategories: Latest Headlines, TransplantationTweet
-
Mashup Score: 0
Journals & BooksRegisterSign inView PDFAccess through your institutionTransplantation and Cellular TherapyVolume 28, Issue 3, Supplement, March 2022, Pages S22-S23Author links open overlay panelSusan E.ProckopMDKris MMahadeoMD, MPHAmerBeitinjanehMDSylvainChoquetMDPatrickStiffMDRanReshefMDGowriSatyanarayanaMDSaurabhDahiyaMDHemaParmarPhDWeiYePhDLaurenceGamelinMD,…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0(PDF) EBV-reactivation and Post- transplant Lymphoproliferative Disorder Treated with Rituximab. - 2 year(s) ago
PDF | We read the recent paper on profile of EBV-associated infectious mononucleosis (IM) by Balasubramanian, et al. with interest. They concluded that… | Find, read and cite all the research you need on ResearchGate
Source: ResearchGateCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Post‐transplant monomorphic Burkitt's lymphoma: Clinical characteristics and outcome of a multicenter series - 2 year(s) ago
Click on the article title to read more.
Source: Wiley Online LibraryCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire - NORD (National Organization for Rare Disorders) - 3 year(s) ago
Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire
Categories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 2Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire - NORD (National Organization for Rare Disorders) - 3 year(s) ago
Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire
Categories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 0Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire - NORD (National Organization for Rare Disorders) - 3 year(s) ago
Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire
Categories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 0Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire - NORD (National Organization for Rare Disorders) - 3 year(s) ago
Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire
Categories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 2Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire - NORD (National Organization for Rare Disorders) - 3 year(s) ago
Externally-Led Patient Focused Drug Development Meeting Speaker Questionnaire
Categories: Latest Headlines, Rare DiseaseTweet
A study of liver transplant recipients found that monitoring them for #EpsteinBarrVirus helped reduce risk for #PTLD: https://t.co/1SY6TpaHpI https://t.co/Ujh0Fnqqr6